Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Taxanes
May 11, 2020
VIVA Physicians Publishes Analysis Evaluating Mortality and Paclitaxel-Coated Devices
Mar 25, 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea® from Oasmia Pharmaceutical
Oct 22, 2019
Global Bulk Paclitaxel Industry
Jul 01, 2019
Boston Biomedical, Inc. Announces Update on Phase 3 CanStem111P Study of Napabucasin in Patients with Metastatic Pancreatic Cancer Following Interim Analysis
Jun 24, 2019
Update on FDA Panel Meeting on Paclitaxel Coated Products
May 22, 2019
United States $20 Bn Breast Cancer Drug Market to 2025: 42 Marketed Drugs, 317 Drugs in Clinical Pipeline by Company, Phase, Drug Class & Patient Segment
Mar 20, 2019
Xynomic Pharmaceuticals, Inc. Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potentially Pivotal Kidney Cancer Trial, and Appoints Interim Chief Accounting Officer
Sep 12, 2018
Oncternal Announces First Patient Dosed in Phase 1b Clinical Trial of Cirmtuzumab in Combination with Paclitaxel in Patients with Breast Cancer
Jun 01, 2018
Boston Biomedical, Inc. Highlights Presentations on Investigational Agents Napabucasin and DSP-7888 (ombipepimut-S*) at ASCO 2018
Apr 30, 2018
AbbVie and Rice University establish K.C. Nicolaou Research Accelerator to advance therapies in oncology
Apr 20, 2018
Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer
Feb 15, 2018
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2018-2024 - Favorable Market Parameters & Commercialization Challenges
Dec 08, 2017
Lilly Reports Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 Study in First-Line Advanced Gastric Cancer
Oct 16, 2017
Rapidly Progressing Advanced Non-Small Cell Lung Cancer Patients Shown to Benefit in New CYRAMZA® (ramucirumab) Phase 3 Subgroup Analysis
Sep 10, 2017
Lilly Builds Upon Body of Clinical Evidence for CYRAMZA® (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer
Jun 26, 2017
Boston Biomedical Announces Unblinding of the Phase 3 Trial in Patients with Advanced Gastric/GEJ Cancer
Jun 26, 2017
NewVac Presented Results of Quisinostat's Phase II Clinical Trial at ASCO 2017
Jun 09, 2017
Yew Bio-Pharm Group Announces the Launch of Its New E-Commerce Website
Jun 04, 2017
Halozyme Phase 2 Data In Advanced Pancreas Cancer Featured In An Oral Presentation At ASCO
May 31, 2017
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA® (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival
Latest News
Apr 25, 2024
Asahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
Apr 25, 2024
Getech Engaged by East Star Resources to Locate Porphyry Copper in Kazakhstan
Apr 25, 2024
Helix Reports First Quarter 2024 Results
Apr 25, 2024
Mativ Announces Appointment of New Chair of its Board of Directors
Apr 25, 2024
Leading Industry Publication: Black & Veatch Remains Among Global Critical Infrastructure Leaders as...
Apr 25, 2024
WM Announces First Quarter 2024 Earnings
Apr 25, 2024
Oceaneering Reports First Quarter 2024 Results
Apr 25, 2024
NewMarket Corporation Reports First Quarter 2024 Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events